Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The aim of this study is to estimate the efficacy of apremilast compared to placebo in the treatment of oral ulcers in pediatric participants from 2 to \< 18 years of age with oral ulcers associated with Behçet\'s disease (BD) through week 12.
Epistemonikos ID: 844a6b57ede29c25f9f5d6d528c448d4b533d8c3
First added on: May 07, 2024